Dextrose Monohydrate 50% Inj · 1,702 days since initial FDA posting
Brand: DEXTROSE MONOHYDRATE
FDA lists Dextrose Monohydrate 50% Inj as Active Shortage (Amphastar Pharmaceuticals, Inc.).
Availability on file: Limited Availability
Dextrose Monohydrate 50% Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dextrose Monohydrate 50% Injection
- Manufacturer
- Amphastar Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Presentation
- Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)
- Package NDC
- 76329-3302-1
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Jan 13, 2022
- Last Updated
- Mar 3, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Avaiable on allocation
Nearby, Other Dextrose Shortage Records
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 5% Injection
B. Braun Medical Inc.
Injection
Dextrose Monohydrate 10% Injection
B. Braun Medical Inc.
Injection
FDA reason on file: Avaiable on allocation. General shortage guidance lives on the tracker hub.